Ishan International IPO

Glenmark Life Science Ltd IPO Review

Glenmark Life Science Ltd IPO Overview

Glenmark Life Sciences, founded in 2011, is the world’s largest producer of active pharmaceutical ingredients (APIs). The company creates high-quality APIs for cardiovascular disease (CVD), central nervous system disease (CNS), pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It also provides services to speciality pharmaceutical firms through Contract Development and Manufacturing Operations (CDMO).
Its products are sold in India and also exported to Europe, North America, Latin America, Japan, and other nations. Currently,As of December 31, 2020, it had 4 manufacturing plants in Gujarat (Ankleshwar and Dahej) and Maharashtra (Mohol and Kurkumbh), with a total yearly installed capacity of 725.8 KL.

Glenmark Life Science Ltd IPO Details

Subscription Dates27 – 29 July 2021
Price BandINR695 – 720 per share
Fresh issueINR1,060 crore 
Offer For Sale63,00,000 shares (INR437.85 – 453.60 crore)
Total IPO sizeINR1,497.85 – 1,513.6 crore 
Minimum bid (lot size)20 shares 
Face Value INR2 per share
Retail Allocation35%
Listing OnNSE, BSE

Glenmark Life Science Ltd IPO Financial Performance

 

FY2018

FY2019

Revenue

1,202.2

1,405.5

Expenses

892.8

1,001.7

Net income

229.5

293.1

Margin (%)

19.1

20.9

 

 

FY2020

FY2021

Revenue

1,549.3

1,886.0

Expenses

1,128.2

1,415.0

Net income

313.6

351.1

Margin (%)

20.2

18.6

Glenmark Life Science Ltd IPO Key Ratios

Earnings Per Share (EPS):  INR32.61
Price/Earnings (PE ratio):   21.31 – 22.08
Return on Net Worth (RONW):  46.71%
Net Asset Value (NAV):  INR69.82 per share

Glenmark Life Science Ltd IPO GMP Trend

Date

Glenmark IPO GMP

5 August 2021

INR90

4 August 2021

INR90

3 August 2021

INR100

2 August 2021

INR110

31 July 2021

INR130

Listing Performance of Glenmark Life Science Ltd IPO

Listed On : Aug 6, 2021

Issue Price : 720  

Listing Day Close : 748.2

Listing Day Gain : 3.92

Glenmark Life Science Ltd IPO ISIN Number Code

NSE : GLS

BSE : 543322 

 ISIN CODE : INE03Q201024 

Glenmark Life Science Ltd IPO Allotment Status

BSE IndiaClick Here

KfintechClick Here

Link InTimeClick Here

Glenmark Life Science Ltd IPO Brokers Reviews & Rating

Ajcon Global – Subscribe
Angel Broking –  Subscribe
Anand Rathi – Subscribe
Arihant Capital – Subscribe
Ashika Research – Subscribe
BP Wealth – Subscribe
Choice Broking – Subscribe
Elite Wealth – Subscribe
Hem Securities – Subscribe
ICICIdirect – Subscribe
Marwadi Financial Services – Subscribe
Prabhudas Lilladher – Subscribe
Samco – Subscribe for listing gains
SMC Global – 3/5
Ventura Securities – Subscribe

Glenmark Life Science Ltd IPO Important Dates

IPO Opening Date: 27 July 2021
IPO Closing Date: 29 July 2021
Finalisation of Basis of Allotment: 3 August 2021
Initiation of refunds: 4 August 2021
Transfer of shares to demat accounts: 5 August 2021
Listing Date: 6 August 2021

Glenmark Life Science Ltd IPO Contact Details

Glenmark House,
B. D. Sawant Marg, Andheri (East),
Mumbai 400099, Maharashtra
Phone: +91 2189 234246

Email: complianceofficer@glenmarklifesciences.com

Website: www.glenmarklifesciences.com

Glenmark Life Science Ltd IPO Registrar Contact Details

KFin Technologies Private Limited

Selenium Tower B, Plot 31-32, Gachibowli, Nanakramguda, Hyderabad – 500 032, Telangana
Phone: +91 40 6716 2222
Fax: +91 40 2343 1551
Email: einward.ris@kfintech.com

Website: www.kfintech.com

Glenmark Life Science Ltd IPO Subscription Details

Category

Shares Offered

Day 1

QIB

42,42,379

0.00

NII

32,32,770

0.85

Retail

75,43,130

5.17

Total

1,50,18,279

2.78

 

Category

Day 2

Day 3

QIB

1.39

36.97

NII

3.40

122.54

Retail

9.28

14.63

Total

5.78

44.17

Glenmark Life Science Ltd IPO FAQ's

Glenmark Life Sciences IPO is a main-board IPO of [.] equity shares of the face value of ₹2 aggregating up to ₹1,513.60 Crores. The issue is priced at ₹695 to ₹720 per equity share. The minimum order quantity is 20 Shares.

The initial public offering (IPO) begins on Jul 27, 2021 and ends on Jul 29, 2021…The registrar for the IPO is Link Intime India Private Ltd. The shares are proposed for listing on the BSE and NSE.

The Glenmark Life Sciences IPO opens on Jul 27, 2021 and closes on Jul 29, 2021.

Glenmark Life Sciences IPO lot size is 20 Shares and the minimum order quantity is 20 Shares.

Glenmark Life Sciences IPO applications can be submitted online using either UPI or ASBA as a payment method. The ASBA IPO application is available in your bank’s net banking. Brokers who do not provide banking services provide UPI IPO applications..Learn more about online IPO applications from Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank, and SBI Bank.

The Basis of Allotment for Glenmark Life Sciences IPO will be done on Aug 3, 2021, and the allotted shares will be credited to your demat account by Aug 5, 2021. Check the Glenmark Life Sciences IPO allotment status.

The Glenmark Life Sciences IPO listing date is on Friday, August 6, 2021.

Glenmark Life Sciences IPO Comments